Literature DB >> 18082613

c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1.

Lei Xu1, Jidong Zhu, Xiaofang Hu, Hong Zhu, Hyoung Tae Kim, Joshua LaBaer, Alfred Goldberg, Junying Yuan.   

Abstract

c-IAP1, a member of the inhibitor of apoptosis protein (IAP) family and a RING finger ubiquitin ligase (E3), has been proposed to be an important oncogene. In many types of cancers, the levels of c-IAP1 are upregulated, which contributes positively to tumorigenesis. However, the mechanism by which c-IAP1 promotes tumorigenesis has proven elusive. Although proteins in the IAP family may function as caspase inhibitors, c-IAP1 was shown to be a poor inhibitor of caspases. Here we show that c-IAP1 catalyzes ubiquitination of Max-dimerization protein-1 (Mad1), a cellular antagonist of Myc. Ubiquitination of Mad1 by c-IAP1 accelerates its degradation by the 26S proteasome pathway, and this reduction of the Mad1 levels cooperates with Myc to promote cell proliferation. Our results demonstrate that c-IAP1 exerts its oncogenic functions by promoting the degradation of an important negative regulator in the Myc pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082613     DOI: 10.1016/j.molcel.2007.10.027

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  35 in total

Review 1.  IAPs: what's in a name?

Authors:  Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

2.  Getting MAD at MYC.

Authors:  Maria Letizia Giardino Torchia; Jonathan D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-10       Impact factor: 11.205

3.  Inhibition of cIAP1 as a strategy for targeting c-MYC-driven oncogenic activity.

Authors:  Haoyan Li; Yanjia Fang; Chunyi Niu; Hengyi Cao; Ting Mi; Hong Zhu; Junying Yuan; Jidong Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

4.  IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation.

Authors:  Tripat Kaur Oberoi; Taner Dogan; Jennifer C Hocking; Rolf-Peter Scholz; Juliane Mooz; Carrie L Anderson; Christiaan Karreman; Dagmar Meyer zu Heringdorf; Gudula Schmidt; Mika Ruonala; Kazuhiko Namikawa; Gregory S Harms; Alejandro Carpy; Boris Macek; Reinhard W Köster; Krishnaraj Rajalingam
Journal:  EMBO J       Date:  2011-11-25       Impact factor: 11.598

5.  cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.

Authors:  Rosanna Lau; Min Ying Niu; M A Christine Pratt
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

6.  Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1.

Authors:  Jidong Zhu; John Blenis; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-01       Impact factor: 11.205

7.  IAP inhibitors enhance co-stimulation to promote tumor immunity.

Authors:  Michael Dougan; Stephanie Dougan; Joanna Slisz; Brant Firestone; Matthew Vanneman; Dobrin Draganov; Girija Goyal; Weibo Li; Donna Neuberg; Richard Blumberg; Nir Hacohen; Dale Porter; Leigh Zawel; Glenn Dranoff
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

8.  RING-finger protein 6 enhances c-Myc-mediated Warburg effect by promoting MAD1 degradation to facilitate pancreatic cancer metastasis.

Authors:  Yumin Qiu; Hengqing Zhu; Debin Xu; Qian Feng; Chongyu Wen; Yunyan Du; Mingfeng Xiang; Leifeng Chen; Xiaogang Peng
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

9.  Dynamic change of TNIK in response to tumor necrosis factor alpha in a TRAF2-dependent manner.

Authors:  Jinghua Gui; Zhenhai Li; Xiumei Zhou
Journal:  Hum Cell       Date:  2013-01-26       Impact factor: 4.174

10.  Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation.

Authors:  Rebecca A Csomos; Casey W Wright; Stefanie Galbán; Karolyn A Oetjen; Colin S Duckett
Journal:  Biochem J       Date:  2009-04-28       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.